5367-60-2Relevant academic research and scientific papers
AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE
-
Page/Page column 48, (2008/06/13)
The invention relates to compounds of Formula (I), wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula (I), are also provided.
4-Fluoro-3-nitro anilines
-
, (2008/06/13)
Compounds of formula: SPC1 Wherein W is EQU1 or EQU2 in which: (a) R4 and R5 are 5 identical or different and represent hydrogen, monovalent aliphatic, substituted or unsubstituted aryl, aralkyl and cycloalkyl, providing that not more than 1 of R4 or R5 is hydrogen, and (b) R3 is a divalent aliphatic radical.
